Skip to main content

Doxepin News

Related terms: Doxepin Topical

Somaxon Announces FDA Approval of Silenor (doxepin) for the Treatment of Insomnia

SAN DIEGO, CA – March 18, 2010 - Somaxon Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Silenor (doxepin) for t...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Insomnia, Irritable Bowel Syndrome, Anxiety, Depression, Urticaria, Hives, Major Depressive Disorder, Neuropathic Pain, Reflex Sympathetic Dystrophy Syndrome

Doxepin patient information at Drugs.com